Summary
An established method for collecting uncontaminated parotid saliva has been applied to assessment of salivary flow rate. Following single doses of 0.3 mg clonidine and 1.0 mg tiamenidine (HOE 440) changes in blood pressure, heart rate, sedation (assessed by a self-rating scale) and salivary flow were followed in nine normal subjects. Both drugs produced a fall in systolic and diastolic blood pressure, sedation, depression of salivary flow and a lowering of heart rate. These changes were maximal between 2 and 6 h and were more marked after clonidine than after timenidine. As tiamenidine 1.0 mg did not produce a hypotensive effect equivalent to clonidine 0.3 mg direct comparison of side-effects attributable to these agents proved difficult. The evidence suggests, however, that tiamenidine would cause sedation and reduction in salivary flow comparable to clonidine if given in an equivalent hypotensive dose.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ashton, H., Rawlins, M. D.: Central nervous system depressant actions of clonidine and UK-14, 304: partial dissociation of EEG and behavioural effects. Br. J. clin. Pharmacol.5, 135–140 (1978)
Davies, D. S., Wing, L. M. H., Reid, J. L., Neill, E., Tippett, P., Dollery, C. T.: Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clin. Pharmacol. Ther.21, 593–601 (1977)
Dollery, C. T., Davies, D. S., Draffan, G. H., Dargie, H. J., Dean, C. R., Reid, J. L., Clare, R. A., Murray, S.: Clinical pharmacology and pharmacokinetics of clonidine. Clin. Pharmacol. Ther.19, 11–17 (1976)
Emmelin, N.: Nervous control of salivary glands. In: Handbook of Physiology, Vol. II, C. F. Code and Heidel, W. (eds.), pp. 595–665. Washington, D. C.: American Physiological Society 1967
Lindner, E., Kaiser, J.: Tiamenidine (HOE 440) a new antihypertensive substance. Arch. Int. Pharmacodyn.211, 305–325 (1974)
Putzeys, M. R., Hoobler, S. W.: Comparison of clonidine and methyldopa on blood pressure and side-effects in hypertensive patients. Am. Heart J.83, 464–468 (1972)
Rand, M. J., Rush, M., Wilson, S.: Some observations on the inhibition of salivation by ST 155. Europ. J. Pharmacol.5, 168–172 (1969)
Reid, J. L., Wing, L. M. H., Mathias, C. J., Frankel, H. L., Neill, E.: The central hypotensive effect of clonidine: studies in tetraplegic subjects. Clin. Pharmacol. Ther.21, 375–381 (1977)
Siegel, S.: In: Non-parametric statistics for the behavioural sciences, pp 75–83. London-New York: McGraw - Hill 1956
Stephen, K. W., Spiers, C. F.: Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology. Br. J. clin. Pharmacol.3, 315–319 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Findlay, D., Lawrence, J.R. An alternative method of assessing changes in salivary flow: Comparison of the effects of clonidine and tiamenidine (HOE 440). Eur J Clin Pharmacol 14, 231–235 (1978). https://doi.org/10.1007/BF00560455
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00560455